Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diabetes Care 2022;45:e3–e6 | https://doi.org/10.2337/dc21-1813 Erika A. Petersen, Thomas G. Stauss, James A. Scowcroft, Elizabeth S. Brooks, Judith L. White, Shawn M. Sills, Kasra Amirdelfan, Maged N. Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G. Patterson, Kostandinos C. Tsoulfas, Michael J. Creamer, Vincent Galan, Richard H. Bundschu, Neel D. Mehta, Dawood Sayed, Shivanand P. Lad, David J. DiBenedetto, Khalid A. Sethi, Johnathan H. Goree, Matthew T. Bennett, Nathan J. Harrison, Atef F. Israel, Paul Chang, Paul W. Wu, Charles E. Argoff, Christian E. Nasr, Rod S. Taylor, David L. Caraway, and Nagy A. Mekhail
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The opioid, tapentadol, has received regulatory approval in the United States and Canada, but evidence for its use is, at best, inconclusive,603,604”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [603]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 1×
“Therapeutic goals include symptom management along with behavioral modifications to mitigate further damage (2).”
BackgroundAbbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M. (2011) · Diabetes Care · doi:10.2337/dc11-1108 · Cited by 868 · cited 1×
“Approximately 20% of persons with diabetes will develop painful diabetic neuropathy (PDN) with paresthesia, burning, and shooting pain (1).”
BackgroundKapural, L., Yu, C., Doust, M. W., Gliner, B. E., Vallejo, R., Sitzman, B. T., Amirdelfan, K., Morgan, D. M., Yearwood, T. L., Bundschu, R., et al. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001418 · Cited by 470 · cited 1×
“data demonstrate that it also results in substantial pain relief for PDN patients (3,4).”
BackgroundSelf-citationPetersen, E. A., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J., Yu, C., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0538 · Cited by 277
Self-citationGupta, M., Knežević, N. N., Abd-Elsayed, A. A., Ray, M., Patel, K. V., & Chowdhury, B. (2021) · Biomedicines · doi:10.3390/biomedicines9050573 · Cited by 53
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Diabetic Neuropathy: Pathophysiology Review
Strand, N. H., Anderson, M. A., Attanti, S., Gill, B., Wie, C. S., Dawodu, A., Pagan-Rosado, R. D., Harbell, M. W., & Maloney, J. A. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01243-5 · Cited by 110
“The clinical manifestations are variable, ranging from asymptomatic to painful neuropathic symptoms [46, 47].”
Petersen, E., Stauss, T. G., Scowcroft, J. A., Jaasma, M. J., Brooks, E. S., Edgar, D. R., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110865 · Cited by 62
“Comparable to the 6-and 12-month study outcomes, the 24-month results confirm the robust and long-lasting beneficial effects of 10 kHz SCS in PDN patients [19,20,30].”
ResultSelf-citationMallick‐Searle, T., & Adler, J. A. (2024) · Journal of Pain Research · doi:10.2147/jpr.s442595 · Cited by 57
Zheng, Y., Liu, C. W., Chan, D. X. H., Ong, D., Ker, J., Ng, W. H., & Wan, K. R. (2023) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2023.05.003 · Cited by 43
Petersen, E., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J. J., Yu, C., et al. (2022) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2022.05.003 · Cited by 38
“27,28,30 This study was designed to be a pragmatic clinical trial 31 with 18 US sites.”
BackgroundSelf-citationConventional management and current guidelines for painful diabetic neuropathy
Tesfaye, S. H., & Kempler, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110765 · Cited by 40
Hoelzer, B. C., Edgar, D. R., Lu, S.-P., & Taylor, R. S. (2022) · Biomedicines · doi:10.3390/biomedicines10102630 · Cited by 21
Self-citationSpinal Cord Stimulation for Painful Diabetic Neuropathy
Yeung, A. M., Huang, J. K., Nguyen, K. T., Xu, N. Y., Hughes, L. T., Agrawal, B. K., Ejskjær, N., & Klonoff, D. C. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221133795 · Cited by 40
Wahezi, S. E., Caparo, M. A., Malhotra, R., Sundaram, L., Batti, K. S., Ejindu, P., Veeramachaneni, R. P., Anițescu, M., Hunter, C., Naeimi, T., et al. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2023.11.002 · Cited by 20
4. Painful diabetic polyneuropathy
Zuidema, X., de Galan, B. E., Brouwer, B. A., Cohen, S. P., Eldabe, S. S., Argoff, C. E., Huygen, F. J. P. M., & Zundert, J. H. M. V. (2023) · Pain Practice · doi:10.1111/papr.13308 · Cited by 38
Self-citationKissoon, N. R., LeMahieu, A., Stoltenberg, A. D., Bendel, M. A., Lamer, T. J., Watson, J. C., Sletten, D. M., & Singer, W. (2023) · Pain Medicine · doi:10.1093/pm/pnad087 · Cited by 17
Trends in spinal cord stimulation utilization: change, growth and implications for the future
Chow, C., & Rosenquist, R. W. (2023) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2023-104346 · Cited by 18
Mekhail, N. A., Levy, R. M., Deer, T. R., Kapural, L., Li, S., Amirdelfan, K., Hunter, C., Rosen, S. M., Costandi, S. J., Falowski, S. M., et al. (2024) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2024-105370 · Cited by 18
“24”
Self-citationHan, Y.-F., & Cong, X. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1366796 · Cited by 14
Spinal cord stimulation in painful diabetic neuropathy: An overview
Petersen, E. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110760 · Cited by 36
Self-citationKlonoff, D. C., Levy, B. L., Jaasma, M. J., Bharara, M., Edgar, D. R., Nasr, C. E., Caraway, D. L., Petersen, E., & Armstrong, D. G. (2024) · Journal of Pain Research · doi:10.2147/jpr.s463383 · Cited by 14
Self-citationZhou, P., Sun, H., & Bao, M. (2024) · Neurosurgery · doi:10.1227/neu.0000000000002866 · Cited by 12
Wu, J., Han, Q., Gui, D., & Qian, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102092 · Cited by 16
“In addition, the satisfaction survey of patients in these clinical trials found that the satisfaction of patients with neural interface treatment was very high, and the majority of patients were very satisfied with the treatment effect [73,75,80].”
Burkey, A. R., Chen, J. L., Argoff, C. E., Edgar, D. R., & Petersen, E. (2023) · Journal of Pain Research · doi:10.2147/jpr.s403715 · Cited by 14
“Extended RCT follow-up to 12 months also underscored this differential response to therapy (86% vs 38–56%).(41,47) The more robust pain relief observed in the 10 kHz SCS RCT compared to the t-SCS studies is consistent with the results of an RCT that directly compared the 2 modalities in patients with chronic back and…”
BackgroundResultInfluentialSelf-citationAbbas, A., Abouelmagd, M. E., El-Moslemani, M., Diaa, A., Samir, A., Ellabban, M. H., Bakr, A., Taha, A. M., Hefnawy, M. T., Moawad, M. H. E. D., et al. (2025) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.01.016 · Cited by 9
Boulton, A. J. M., Jensen, T. S., Luecke, T. D., Petersen, E., Pop‐Busui, R., Taylor, R. S., Tesfaye, S. H., Vileikytė, L., & Ziegler, D. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110763 · Cited by 7
Self-citationNeuropatía Diabética: Una revisión narrativa de fisiopatología, diagnóstico y tratamiento.
Jiménez-Castillo, G. A., Martínez‐Bravo, L. E., & Anaya‐Escamilla, A. (2023) · ACTA MEDICA PERUANA · doi:10.35663/amp.2023.403.2731 · Cited by 15
Henney, A. E., Frank, B., Riley, D. R. J., Anson, M., Burgess, J., Hernadez, G., Lip, G. Y. H., Malik, R. A., Tesfaye, S. H., Cuthbertson, D. J., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103489 · Cited by 7
“16 Moreover, studies assessing SCS in patients with PDN are often limited to evaluating pain relief over short follow-up (typically 16–18 months; although there has been recent 24–48-month clinical trial data, as well as 10-year follow-up data from the Maastricht study).”
Stimulating Results Signal a New Treatment Option for People Living With Painful Diabetic Neuropathy
Armstrong, D. G., & Grunberger, G. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221099542 · Cited by 5
Spinal Cord Stimulation in Painful Diabetic Neuropathy: Advances, Outcomes, and Future Directions
Gazzeri, R., Mosca, J., Occhigrossi, F., Galarza, M., Schiaffini, R., Varrassi, G., Mercieri, M., & Leoni, M. L. G. (2025) · Biomedicines · doi:10.3390/biomedicines13123063 · Cited by 5
“In fact, high-frequency SCS, particularly the 10 kHz modality, has markedly changed clinical practice by offering effective pain relief without inducing paresthesia [31,59,60].”
Stellenwert der Rückenmarkstimulation bei schmerzhafter diabetischer Polyneuropathie
Ziegler, D., Luecke, T. D., Ahmadi, R., Maciaczyk, J., Siegel, E. G., Sommer, C., & Rasche, D. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2542-0518 · Cited by 4
“Einen Überblick zu der aktuell verfügbaren Literatur und Evidenz zeigen ▶ Tab.1 und ▶ Tab.2 [67, 68, 69, 70, 71, 72, 73].”
Diabetes Technology Meeting 2022
Huang, J. K., Yeung, A. M., DuBord, A. Y., Wolpert, H. A., Jacobs, P. G., Lee, W.-A., Drincic, A., Spanakis, E. K., Sherr, J. L., Prahalad, P., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221148743 · Cited by 6
Tesfaye, S. H., & Didangelos, T. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_3 · Cited by 3
German National Guidelines for Epidural Spinal Cord Stimulation for the Treatment of Chronic Pain
Vesper, J., Weski, J., & Slotty, P. J. (2025) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.03.070 · Cited by 2
Therapeutic and Diagnostic Landscape of Diabetic Neuropathy: A Systematic Review of Clinical Studies
Rajput, J. P. S., Deb, R., Saiyad, S. S., Jamal, Z., Sah, S. K., Vara, A. R., Sandhu, N., Rochlani, D., Saiyed, T. A., Pathan, A. A., et al. (2026) · Cureus · doi:10.7759/cureus.102825 · Cited by 4
Can Spinal Cord Stimulation be Considered as a Frontier for Chronic Pain in Diabetic Foot?
Zhang, Y., Zhang, H., Wang, K., Liu, X., & Li, Z. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00710-0 · Cited by 3
“Mean VAS decreased to 2.0 cm at 12 months, and concomitant improvements in health regulated quality of life, sleep, and neurologic function were noted [50, 100].”
InfluentialCui, D., Yang, M., Qiao, Y., Gong, Z., Hu, Z., Ma, Z., Wu, Y., & Huo, G. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1619851 · Cited by 1
Negri, P. D., Negri, C. D., & Turco, F. (2025) · Pain Management · doi:10.1080/17581869.2025.2577089 · Cited by 1
Awad, G., Boutros, M., Abboud, E., Mjahed, G. A., & Yammine, K. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.03.008 · Cited by 1
Leitlinie zur epiduralen Rückenmarkstimulation bei chronischen neuropathischen Schmerzen
Slotty, P. J., Rasche, D., & Vesper, J. (2026) · Der Schmerz · doi:10.1007/s00482-026-00939-4 · Cited by 1
Sharan, A. D., Hatheway, J. A., Murphy, M. Z., Dann, T., Fishman, M. A., Zuidema, X., Zundert, J. H. M. V., LaRue, M., & Slangen, R. (2023) · Diabetes Care · doi:10.2337/dc22-2491 · Cited by 1
Argoff, C. E. (2022) · Neurology · doi:10.1212/wnl.0000000000201549
Self-citationHenney, A. E., Frank, B., Riley, D. R. J., Anson, M., Burgess, J., Hernández, G., Lip, G. Y. H., Malik, R. A., Tesfaye, S. H., Cuthbertson, D. J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5114592
Rethink of the New Treatment for Refractory Painful Diabetic Peripheral Neuropathy [Letter]
Wang, Y., Zhang, Y., & Chen, J. (2025) · Journal of Pain Research · doi:10.2147/jpr.s518245
Neuromodulation therapierefraktärer Schmerzen – ein Update
Bayerl, S. (2025) · Die Wirbelsäule · doi:10.1055/a-2121-2841
Zhou, Q., & Guo, J. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2504451
Clinical States of Pain (Taxonomy)
Hooten, W. M., D'Souza, R. S., & Nelson, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-88357-6_3 · Cited by 1
Non-Pharmacological Therapies in the Management of Painful Diabetic Neuropathy: A Literature Review
Arpinte, C. A., Atanasescu, A. G., Pistritu, D. V., Apetrei, A., Pisculungeanu, M. A., & Guja, C. (2025) · Critical Reviews in Physical and Rehabilitation Medicine · doi:10.1615/critrevphysrehabilmed.2025058289
Qin, X., & Chen, L. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1755822
Saw, M., Agababaeva, R., Sabri, M. A., Russo, M., Hunter, C., Wahezi, S. E., Poree, L., & Bikson, M. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.07.642 · Cited by 1
Larson, E. M., Dalm, B., & Townsend, K. L. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1892683
“At present, evidence remains insufficient to support routine implantation at the time of diagnosis or in asymptomatic individuals because the available clinical trials have primarily enrolled patients with painful, refractory DPN (21, 23, 24, 73).”
Chen, X., Zhu, B., & Li, Z. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.07.020
Metadata
- Authors
- Petersen, E. A., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J., Yu, C., Nairizi, A., Patterson, D. G., Tsoulfas, K. C., Creamer, M. J., Galan, V., Bundschu, R. H., Mehta, N. D., Sayed, D., Lad, S. P., DiBenedetto, D. J., Sethi, K. A., Goree, J. H., Bennett, M. T., Harrison, N. J., Israel, A. F., Chang, P., Wu, P. W., Argoff, C. E., Nasr, C. E., Taylor, R. S., Caraway, D. L., & Mekhail, N. A.
- Affiliations
- University of Arkansas for Medical Sciences (US)
- 2Advanced Pain Management, Greenfield, WI
- 3D Medicines, Inc. (China) (CN)
- Nevro (United States) (US)
- Compass Research (US)
- 6Touchstone Interventional Pain Center, Medford, OR
- 7IPM Medical Group, Walnut Creek, CA
- Ochsner Health System (US)
- Cleveland Clinic (US)
- Swedish Medical Center (US)
- Chicago Anesthesia Pain Specialists (US)
- 12Central Florida Pain Relief Centers, Orlando, FL
- 13Pain Care, Stockbridge, GA
- Coastal Orthopedics (US)
- Weill Cornell Medicine (US)
- University of Kansas Medical Center (US)
- Duke University (US)
- 18Boston PainCare, Waltham, MA
- United Health Services (US)
- Holy Cross Hospital (US)
- Albany Medical Center Hospital (US)
- University of Glasgow (GB)
- Corresponding author
- Petersen, Erika A.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-11-29
- Volume
- 45
- Issue
- 1
- Pages
- e3-e6
- ISSN
- 0149-5992 (ISSN-L)
- PMC
- PMC8753758
- OpenAlex
- W3216590849
- Cited by
- 48
- References
- 5
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 8 · 2023: 12 · 2022: 6
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Funders
- National Cancer Institute (K08CA228039)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- spinal cord stimulation, high-frequency stimulation, 10 kHz stimulation, diabetic neuropathic pain, refractory pain, treatment durability, chronic pain management
- MeSH terms
- Diabetes Mellitus, Diabetic Neuropathies, Humans, Pain Measurement, Treatment Outcome, Chronic Pain, Pain Management, Spinal Cord Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.